Natera officer Michael Brophy proposes $831K sale
The reported three-month sales list includes five transactions, with two specifically labeled under a 10b5-1 Sales Plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Natera, Inc. officer Michael Brophy reported a proposed sale of 1,906 common shares, with an aggregate market value of $831,016.00 and an approximate sale date of October 30, 2026, through Morgan Stanley Smith Barney LLC. The shares are listed as acquired from the issuer on October 27, 2026, through restricted stock units. Past sales listed from July 31, 2026, through October 28, 2026, include two identified as under a 10b5-1 Sales Plan.
Key Figures
Key Terms
Restricted Stock Units financial
10b5-1 Sales Plan regulatory
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which of Michael Brophy’s past NTRA sales were identified under a 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.